Barclays Upgrades Abbott, Sees 'Selling Overdone'
October 07, 2015 at 08:28 AM EDT
Shares of Abbott Laboratories (NYSE: ABT) have declined 19.8 percent over the last three months, hitting a low of $39.06 on ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.